𝔖 Bobbio Scriptorium

✦ LIBER ✦

S27-2 Changing Trends of Clinical Trials in Korea after ICH

✍ Scribed by Sang-Goo Shin

Book ID: 119638565
Publisher: Elsevier
Year: 2009
Tongue: English
Weight: 51 KB
Volume: 4
Category: Article
ISSN: 1875-4570
DOI: 10.1016/s1875-4570(09)60144-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintenance of Clinical Efficacy After D

Maintenance of Clinical Efficacy After Dose Reduction of Ixabepilone Plus Capecitabine in Patients With Anthracycline- and Taxane-Resistant Metastatic Breast Cancer: A Retrospective Analysis of Pooled Data From 2 Phase III Randomized Clinical Trials

✍ Vicente Valero; Eduard Vrdoljak; Binghe Xu; Eva Thomas; Henry Gómez; Alexey Mani 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 405 KB

AS-42: A Randomized Comparison of Triple

AS-42: A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy in Patients at High-Risk of Restenosis after Drug-Eluting Stent Implantation: 2-year Clinical Outcomes of DECLARE-DIABETES and LONG Trials

✍ Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 30 KB

40 kDa peginterferon alfa-2A (PEGASYS®)

40 kDa peginterferon alfa-2A (PEGASYS®) as a prophylaxis against hepatitis C infection recurrence after liver transplantation (LT): preliminary results of a randomized multicenter trial: Cosme Manzarbeitia, Albert Einstein Medical Center, Philadelphia, PA; Lewis Tepermann, New York University Medical Center, New York, NY; Naga Chalasani, Indiana University Medical Center, Indianapolis, IN; Patricia Sheiner, Mount Sinai Medical Center, New York, NY; Russel Wiesner, The Mayo Clinic, Rochester, MN; Ian M Marks, Lucy Wynohradnyk, S. Chris Pappas, Roche Laboratories Inc, Nutley, NJ

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB